Nikhil Chopra, India Business Head, Cipla speaks on busting myths on asthma and Ciplas' #BerokZindagi initiative to lead a better life in a conversation with Prabhat Prakash
![Our Ambition Is To Change Attitudes And Make Uninhibited Living A Habit.](https://magarticles.magzter.com/articles/5843/333187/5c7ceda3d28cd/Our-Ambition-Is-To-Change-Attitudes-And-Make-Uninhibited-Living-A-Habit.jpg)
What is the incidence rate of asthma in India? How huge is the disease burden?
In India, 93 million people suffer from chronic respiratory diseases, of which 38 million people are diagnosed as asthmatics. One must note that these chronic respiratory diseases cause the second largest mortality after cardiovascular diseases. (Source: https:// www.thelancet.com/journals/lan glo/article/PIIS2214109X(18)30409-1/fulltext) Doctors across the nation see an average of around 30-40 patients suffering from respiratory diseases like asthma on a daily basis, and there is absolutely no sign of reduction of the disease burden. In fact, last year saw a whopping 25 per cent increase in the number of people suffering from respiratory symptoms compared to the previous year. It is estimated that one-third of the population will develop asthma at some point, and mostly before the age of 20. Factors such as the rise of particulate matter in the air, pollen, smoking, food habits, nutritional deficiency, hereditary predisposition and largely ignorance amongst parents only increase the prevalence of the disease.
As asthma is a chronic disease it poses a lot of economic burden on the patient. Is cost a deterrent?
Higher initial costs tend to hinder the adoption of consistent therapy for asthma in the lower socio-economic groups. However, if one considers the price bracket of inhalers which is the mainstay for treatment, a patient needs to shell out a daily cost of less than ̀ 10. Also, the range of solutions that we offer for asthma in India is not available anywhere else at such accessible prices. Hence, we can say that in terms of reasons for not adopting inhalation therapy for asthma, the lack of awareness and prevailing misconceptions about it far surpass the factor of cost burden for non-adoption.
ãã®èšäºã¯ Express Pharma ã® March 01-15, 2019 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã8,500 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Express Pharma ã® March 01-15, 2019 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã8,500 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
![Achieving Aatmanirbharta In APIs Are We On The Right Track?](https://reseuro.magzter.com/100x125/articles/5843/714758/61079751e3674/crp_ACHIEVING-AATMANIRBHARTA-IN-APIs-ARE-WE-ON-THE-RIGHT-TRACK.jpg)
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
![Yokogawa launches OpreX Data Model Broker](https://reseuro.magzter.com/100x125/articles/5843/714758/61079ab7f00b1/crp_Yokogawa-launches-OpreX-Data-Model-Broker.jpg)
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
![Understanding the nuances of generics injectables](https://reseuro.magzter.com/100x125/articles/5843/714758/610795ba08ab5/crp_Understanding-the-nuances-of-generics-injectables.jpg)
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
![Trending in nutraceuticals: Science meets sustainability](https://reseuro.magzter.com/100x125/articles/5843/714758/6107992e53656/crp_Trending-in-nutraceuticals-Science-meets-sustainability.jpg)
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticalsâ development around the globe
![The growth of e-pharmacies in India](https://reseuro.magzter.com/100x125/articles/5843/714758/610794bd4b3ef/crp_The-growth-of-e-pharmacies-in-India.jpg)
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
![Xylitol and Maltitol: Low-calorie sugar alternatives](https://reseuro.magzter.com/100x125/articles/5843/714758/61079bfe86411/crp_Xylitol-and-Maltitol-Low-calorie-sugar-alternatives.jpg)
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
![Single-use TC gaskets and their importance](https://reseuro.magzter.com/100x125/articles/5843/714758/61079a010a02f/crp_Single-use-TC-gaskets-and-their-importance.jpg)
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.
![It's important to enhance customer experience so that existing customers are more loyal](https://reseuro.magzter.com/100x125/articles/5843/714758/610793e13e8be/crp_Its-important-to-enhance-customer-experience-so-that-existing-customers-are-more-loyal.jpg)
It's important to enhance customer experience so that existing customers are more loyal
Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury
![From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice](https://reseuro.magzter.com/100x125/articles/5843/714758/610798319bb2f/crp_From-HIV-to-COVID-19-The-role-of-liposomal-nanotechnology-as-an-NDDS-of-choice.jpg)
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment
![Ensuring pharma compliance with testo data loggers](https://reseuro.magzter.com/100x125/articles/5843/714758/61079b4500cd2/crp_Ensuring-pharma-compliance-with-testo-data-loggers.jpg)
Ensuring pharma compliance with testo data loggers
Testo data loggers can be used to test the optimum conditions for specific products or surroundings